|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07D 401/12 | |
| C07D 401/14 | |||
| C07D 405/14 | |||
| C07D 413/14 | |||
| A61K 31/4439 | |||
| A61P 25/00 |
| (11) | Patento numeris | 2590963 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11728862.1 |
| Europos patento paraiškos padavimo data | 2011-07-04 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-05-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2014-12-03 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/061168 |
| Data | 2011-07-04 |
| (87) | Numeris | WO 2012/004207 |
| Data | 2012-01-12 |
| (30) | Numeris | Data | Šalis |
| 10168688 | 2010-07-07 | EP |
| (72) |
NETTEKOVEN, Matthias, DE
RATNI, Hasane, FR
VIFIAN, Walter, CH
|
| (73) |
F. Hoffmann-La Roche AG,
Grenzacherstrasse 124, 4070 Basel,
CH
|
| (54) | (3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |
| (3-METHYLPYRROLIDIN-3-YL)METHYL PYRIDINYL ETHER DERIVATIVES AND THEIR USE AS NK-3 RECEPTOR ANTAGONISTS |